Authors
Loading...
Single-cell transcriptomic analysis reveals ARHGEF26 downregulation in podocytes during early diabetic kidney disease, highlighting its potential as a diagnostic biomarker and therapeutic target.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: